Francis A. Farraye, MD

Adjunct Professor, Medicine

Francis Farraye
617.638.8339
85 E. Concord St

Biography

Dr. Farraye is a Senior Associate Consultant in the Section of Gastroenterology and Hepatology at the Mayo Clinic in Jacksonville Florida where he co-directs the Inflammatory Bowel Disease Center. Prior to relocating in 2019, he was Clinical Director in the Section of Gastroenterology and the Inflammatory Bowel Disease Center at Boston Medical Center. At Chobanian and Avedisian School of Medicine, he was Professor of Medicine. Dr. Farraye earned his medical doctorate from the Albert Einstein College of Medicine in New York and his master’s degree in Epidemiology from the Harvard School of Public Health.

Dr. Farraye’s clinical interests are in the care of patients with inflammatory bowel disease. He is currently investigating C. difficile infection in IBD patients, the management and diagnosis of dysplasia and cancer in patients with IBD; social media use and health literacy in IBD patients; hepatitis B vaccination efficacy in patients with IBD; and subclinical hepatic fibrosis in patients with IBD.

A frequent speaker and invited lecturer on topics on the diagnosis and management of inflammatory bowel disease, Dr. Farraye has authored or co-authored over 450 original scientific manuscripts, book chapters, reviews, and abstracts. He is the series editor for the text Curbside Consultations in Gastroenterology and co-edited the text, Curbside Consultation in Inflammatory Bowel Disease and Gastrointestinal Emergencies. His books for patients include Questions and Answers about Ulcerative Colitis, Questions and Answers about Crohn’s Disease and Ulcerative Colitis for Dummies.

Dr. Farraye is a Fellow of the American Society of Gastrointestinal Endoscopy, American Gastroenterological Association and the American College of Gastroenterology. He has served on numerous national and international committees including as a member of the ACG Board of Trustees. He is co-chair of the Crohn’s and Colitis Foundation Membership Committee and a member of the Chapter Medical Advisory Committee for the New England Crohn’s and Colitis Foundation and a past chairman. The New England Crohn’s and Colitis Foundation named Dr. Farraye Humanitarian of the Year in 2003. In 2009, the ACG awarded Dr. Farraye the William Carey Award for service to the college. Dr. Farraye has been recognized as “Top Doctor” in Gastroenterology by Boston Magazine and U.S. News and World Report since 2010.

Other Positions

  • Member, Center for Regenerative Medicine, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • Albert Einstein College of Medicine, MD
  • Harvard School of Public Health, MSc
  • Stony Brook University, BS

Publications

  • Published on 7/3/2024

    Desai A, Soni A, Hayney MS, Hashash JG, Kochhar GS, Farraye FA, Caldera F. Increased Risk of Herpes Zoster in Adult Patients with Inflammatory Bowel Disease After SARS-CoV2 Infection: A Propensity-Matched Cohort Study. Inflamm Bowel Dis. 2024 Jul 03; 30(7):1094-1102. PMID: 37540900.

    Read at: PubMed
  • Published on 6/27/2024

    Desai A, Petrov J, Hashash JG, Patel H, Brahmbhatt B, Kochhar GS, Farraye FA. Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease. Aliment Pharmacol Ther. 2024 Jun 27. PMID: 38938071.

    Read at: PubMed
  • Published on 6/21/2024

    Ley D, Lazarus S, Forati AM, Farraye FA, Smith R, Hayney MS, Caldera F. High Rates of Seroprotection to Hepatitis B After a Hepatitis B Challenge Dose in Previously Vaccinated Patients with Inflammatory Bowel Disease on Immunosuppressive Therapy. Dig Dis Sci. 2024 Jun 21. PMID: 38907090.

    Read at: PubMed
  • Published on 6/20/2024

    Karime C, Vattikonda A, Hashash JG, Rosser BG, Merchea A, Stocchi L, Farraye FA. Successful Preoperative Transjugular Intrahepatic Portosystemic Shunt for Portal Decompression in Patients With Inflammatory Bowel Disease and Cirrhosis Requiring Surgical Intervention. Crohns Colitis 360. 2024 Jul; 6(3):otae037. PMID: 38966121.

    Read at: PubMed
  • Published on 6/18/2024

    Barnes EL, Desai A, Hashash JG, Farraye FA, Kochhar GS. The Natural History After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis: A Population-Based Cohort Study From the United States. Am J Gastroenterol. 2024 Jun 18. PMID: 38888231.

    Read at: PubMed
  • Published on 6/14/2024

    Siu RK, Karime C, Hashash JG, Kinnucan J, Picco MF, Farraye FA. Sirolimus Use in Refractory Crohn's Disease. ACG Case Rep J. 2024 Jun; 11(6):e01368. PMID: 38883582.

    Read at: PubMed
  • Published on 6/3/2024

    Alsakarneh S, Desai A, Kochhar GS, Farraye FA, Hashash JG. Treatment of Chronic Pouchitis With JAK Inhibitors: Results from A Large Multicenter Database. Inflamm Bowel Dis. 2024 Jun 03. PMID: 38830629.

    Read at: PubMed
  • Published on 6/3/2024

    Desai A, Hashash JG, Kochhar GS, Hayney MS, Caldera F, Farraye FA. Recombinant Zoster Vaccine [RZV] is Effective in Patients with Inflammatory Bowel Disease: A US Propensity Matched Cohort Study. J Crohns Colitis. 2024 Jun 03; 18(6):828-835. PMID: 38224526.

    Read at: PubMed
  • Published on 5/8/2024

    Karime C, Black CN, Cortes P, Kwon JY, Caldera F, Crosby SK, Picco MF, Kinnucan JA, Hashash JG, Farraye FA. Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B Vaccination. Am J Gastroenterol. 2024 May 08. PMID: 38717045.

    Read at: PubMed
  • Published on 4/27/2024

    Wang Y, Pan CW, Huang Y, Zheng X, Li S, He M, Hashash JG, Farraye FA, Ehrlich AC. Global Epidemiology and Geographic Variations of Pediatric-Onset Inflammatory Bowel Disease: A Comprehensive Analysis of the Global Burden of Disease Study 1990 to 2019. Inflamm Bowel Dis. 2024 Apr 27. PMID: 38676392.

    Read at: PubMed

View 475 more publications: View full profile at BUMC

View all profiles